Gene · 5798
Papers3,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Potential Therapeutic Targets of PTPN Families for Lung Cancer. | J Pers Med | 2022 | 36556168 | PubTator, text mining | PubMed |
| Functional and Taxonomic Traits of the Gut Microbiota in Type 1 Diabetes Children at the Onset: A Metaproteomic Study. | Int J Mol Sci | 2022 | 36555624 | PubTator, text mining | PubMed |
Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis. | Int J Mol Sci | 2022 | 36555449 | PubTator, text mining | PubMed |
| Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology. | Front Endocrinol (Lausanne) | 2022 | 36531463 | PubTator, text mining | PubMed |
| Association Between Serum Vitamin D Levels and Ketosis Episodes in Hospitalized Patients with Newly Diagnosed Ketosis-Prone Type 2 Diabetes. | Diabetes Metab Syndr Obes | 2022 | 36530585 | PubTator, text mining | PubMed |
| Multi-omic interactions in the gut of children at the onset of islet autoimmunity. | Microbiome | 2022 | 36527134 | PubTator, text mining | PubMed |
| ADAR1-dependent editing regulates human β cell transcriptome diversity during inflammation. | Front Endocrinol (Lausanne) | 2022 | 36518246 | PubTator, text mining | PubMed |
| Algorithmic identification of atypical diabetes in electronic health record (EHR) systems. | PLoS One | 2022 | 36508462 | PubTator, text mining | PubMed |
| Global miRNA expression reveals novel nuclear and mitochondrial interactions in Type 1 diabetes mellitus. | Front Endocrinol (Lausanne) | 2022 | 36506063 | PubTator, text mining | PubMed |
| Tolerogenic dendritic cells pulsed with islet antigen induce long-term reduction in T-cell autoreactivity in type 1 diabetes patients. | Front Immunol | 2022 | 36505460 | PubTator, text mining | PubMed |
| An Ultra-Precision Absolute-Type Multi-Degree-of-Freedom Grating Encoder. | Sensors (Basel) | 2022 | 36501749 | PubTator, text mining | PubMed |
| CT-Based Radiomic Analysis for Preoperative Prediction of Tumor Invasiveness in Lung Adenocarcinoma Presenting as Pure Ground-Glass Nodule. | Cancers (Basel) | 2022 | 36497379 | PubTator, text mining | PubMed |
| Association between type 1 diabetes and neurodevelopmental disorders in children and adolescents: A systematic review and meta-analysis. | Front Psychiatry | 2022 | 36483136 | PubTator, text mining | PubMed |
| Autoreactivity and broad neutralization of antibodies against HIV-1 are governed by distinct mutations: Implications for vaccine design strategies. | Front Immunol | 2022 | 36479128 | PubTator, text mining | PubMed |
| Risk factor analysis and clinical decision tree model construction for diabetic retinopathy in Western China. | World J Diabetes | 2022 | 36437866 | PubTator, text mining | PubMed |
| Vitamin D and Beta Cells in Type 1 Diabetes: A Systematic Review. | Int J Mol Sci | 2022 | 36430915 | PubTator, text mining | PubMed |
| Clinical Significance of Diabetes-Mellitus-Associated Antibodies in Rheumatoid Arthritis. | Cells | 2022 | 36429105 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Identifies Tumor Cell Surface Targets for CAR-T Cell Therapies and Antibody Drug Conjugates. | Cancers (Basel) | 2022 | 36428765 | PubTator, text mining | PubMed |
| Fulminant Type 1 Diabetes Mellitus after SARS-CoV-2 Vaccination: A Case Report. | Vaccines (Basel) | 2022 | 36423001 | PubTator, text mining | PubMed |
| A Novel GCK Large Genomic Rearrangement in a Patient with MODY-2 Detected by Clinical Exome Sequencing. | Genes (Basel) | 2022 | 36421779 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5798/papers?page=20